Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Medicines Containing The Active Ingredient Combination Brinzolamide And Brimonidine (atc 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-12-31
Germany Drug Discount Agreements From 01.03.2025 For Various Active Ingredients Within The Framework Of An Open House Procedure 2027-01-04
United Kingdom Provision Of Care Services In Supported Housing 2027-01-05
Ireland Dynamic Purchasing System For Non Invasive Cardiology Equipment 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Telmisartan + Amlodipine, (obg) Atc C09db04 For The Period 01.03.2025 28.02.2027 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Ingredient Erythropoietin, Excluding Epoetin Alfa, (obo) Atc B03xa01 For The Period 01.03.2025 - 28.02.2027 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb) V For The Active Ingredient Elbasvir + Grazoprevir, (obo) Atc J05ap54 For The Period 01.03.2025 - 28.02.2027 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Atovaquone, (obg) Atc P01ax06 For The Period 01.03.2025 - 28.02.2027 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Progesterone Exclusively In The Dosage Form Vka 2027-01-05
Whats app